Aseptika Limited (Activ8rlives), Huntingdon, Cambridgeshire, UK:
Aseptika (Activ8rlives) has scooped another major accolade after being selected for the Inaugural Digital Health Global 100 Award List. The Global Award has been developed as a comprehensive assessment of the most innovative companies working in the digital and mobile healthcare sector.
The Global Digital Health 100 Award acknowledges the significant work and innovation being carried out in this field by pioneering organisations from around the globe, reflecting the importance of mobile and digital solutions. The Award selection process was undertaken by the editorial team at The Journal of mHealth based on ten different quantitative and qualitative evaluation criteria including: disruptive impact, proof of concept, technology innovation, social value, execution of strategy, and industry integration. An initial list of 1,500 offerings, innovations and companies were considered before the selection of the final 100.
The Journal of mHealth editorial team has: “selected the 100 companies that demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria meant that we were able to truly consider companies based upon innovation, comparing start-up offerings alongside established and larger organisations.”
Commenting on the most recent accolade, Kevin A. Auton Ph.D., Founder and Managing Director of Aseptika Limited said:
“To be recognised as a part of this global list of innovative and pioneering organisations working in mobile and digital healthcare is a tremendous honour. This tops off an exciting and dynamic year in 2014 for Aseptika. It is a testament to the hard work and dedication of staff, clinical and technology partners and the SBRI Healthcare team, without whom we would not have been able to develop our solutions, which have enabled patients and their carers to learn from their data and to better self-manage this long-term condition. We need a new generation of simple tools to help us, our families and the network of our clinical supporters, achieve these goals and reduce the growing pressure on our NHS and social care.”